Contact
searchSearch
HMP Global

Commentaries

Mark Hinkes DPM FACFAS FAPWCA DABFAS
Blog
Patient Education and Prevention of Diabetic Foot Ulcers
11/17/2022
Information on the development of foot ulcers and how to prevent them is a critical component of patient diabetes education and the prevention of foot pathology. How much do your patients know about their foot health and how does that...
Information on the development of foot ulcers and how to prevent them is a critical component of patient diabetes education and the prevention of foot pathology. How much do your patients know about their foot health and how does that...
Information on the development...
11/17/2022
Podiatry Today
Lesly Robinson, DPM
Blog
Could Neuropathic Pain Be a Consequence of Treatment for Diabetes?
03/16/2022
In this blog, Dr. Robinson shares evidence that suggests that neuropathic pain may have an association with treatment for, not just as a symptom of, diabetes.
In this blog, Dr. Robinson shares evidence that suggests that neuropathic pain may have an association with treatment for, not just as a symptom of, diabetes.
In this blog, Dr. Robinson...
03/16/2022
Podiatry Today
Commentary
Early Recognition, Clinical Intervention Key to Improving Outcomes for Pediatric Type 2 Diabetes, Obesity, and PCOS
03/03/2022
Yvette C Terrie, BS Pharm, RPh, highlights the prevalence of comorbidities associated with type 2 diabetes and polycystic ovarian syndrome among pediatric patients, emphasizing how providers can help improve outcomes.
Yvette C Terrie, BS Pharm, RPh, highlights the prevalence of comorbidities associated with type 2 diabetes and polycystic ovarian syndrome among pediatric patients, emphasizing how providers can help improve outcomes.
Yvette C Terrie, BS Pharm, RPh,...
03/03/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
New Research: A Physiological Link Between Hypertension and Diabetes
02/08/2022
Mark Munger, PharmD, FCCP, FACC, reviews new research and considers whether existing or new agents could be used to target both hypertension and diabetes.
Mark Munger, PharmD, FCCP, FACC, reviews new research and considers whether existing or new agents could be used to target both hypertension and diabetes.
Mark Munger, PharmD, FCCP, FACC,...
02/08/2022
Pharmacy Learning Network
Commentary
The Diabetes Epidemic: Urgent Need to Emphasize Prevention, Detection, Management of Type 2 Diabetes
12/02/2021
“…it is imperative that clinicians—including pharmacists—expand patient education initiatives to augment awareness about the serious health consequences associated with diabetes," writes Yvette C Terrie, BS Pharm.
“…it is imperative that clinicians—including pharmacists—expand patient education initiatives to augment awareness about the serious health consequences associated with diabetes," writes Yvette C Terrie, BS Pharm.
“…it is imperative that...
12/02/2021
Pharmacy Learning Network
Headshot of German Hernandez, fellow of the American Society of Nephrology
Commentary
Diabetes Awareness Month: Nutrition Tips for Managing Type 2 Diabetes and ADPKD
11/18/2021
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides nutrition tips for patients living with autosomal dominant polycystic kidney disease and stresses that “incorporating them into a patient’s routine as soon as diagnosis is confirmed may make a difference in...
German Hernandez, MD, provides...
11/18/2021
First Report Managed Care

In the News

News
First Allogeneic Pancreatic Islet Cellular Therapy Is Approved for Type 1 Diabetes
06/28/2023
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new...
06/28/2023
Endocrinology & Diabetes
News
Class I Recall for Thyroid Medication
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Veradigm and HealthVerity Collaborate to Advance Real-World Evidence and Care for Patients with Cardiovascular Disease and Diabetes
02/13/2023
Veradigm®, a leading provider of healthcare data and technology solutions, and HealthVerity®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, announced a collaboration that will advance real-world research...
Veradigm®, a leading provider of healthcare data and technology solutions, and HealthVerity®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, announced a collaboration that will advance real-world research...
Veradigm®, a leading provider of...
02/13/2023
EP Lab Digest
News
Assessing Bone Health in Long-term Care Residents With Diabetes
01/04/2023
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using...
01/04/2023
Annals of Long-Term Care
News
Complex Medication Regimens Associated With Poorer Type 2 Diabetes Outcomes
01/03/2023
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
News
Does New-Onset Diabetes Predict Pancreatic Cancer?
01/02/2023
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals...
01/02/2023
Gastroenterology
News
Study Observes Damage to Thyroid Gland in Fatal Burn Patients
09/07/2022
A recent histopathological study confirmed follicular distortion of the thyroid gland in medicolegal autopsy of 64 patients who suffered fatal burn wounds, highlighting the possible benefit of thyroid hormone supplementation in burn patients.
A recent histopathological study confirmed follicular distortion of the thyroid gland in medicolegal autopsy of 64 patients who suffered fatal burn wounds, highlighting the possible benefit of thyroid hormone supplementation in burn patients.
A recent histopathological study...
09/07/2022
Wound Care
News
Thyroid, Growth Hormones in Children Unaffected by 1 Year of Low-Dose ADHD Drugs
05/02/2022
Low-dose medications to manage symptoms of attention-deficit/hyperactivity disorder (ADHD) do not appear to be associated with changes in thyroid and growth hormones over 1 year of treatment.
Low-dose medications to manage symptoms of attention-deficit/hyperactivity disorder (ADHD) do not appear to be associated with changes in thyroid and growth hormones over 1 year of treatment.
Low-dose medications to manage...
05/02/2022
Psych Congress Network
Diabetes Watch
Examining The Expanding Clinical Benefits Linked With Metformin Use
01/26/2022
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author...
01/26/2022
Podiatry Today
News
Diabetes Drugs Cost Less Under Medicaid vs Marketplace Plans in Colorado
01/17/2022
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with diabetes experienced lower total costs and higher utilization rates compared to those covered by Marketplace plans in Colorado.
Medicaid-eligible patients with...
01/17/2022
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use